Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-06

Clinical Trial Update: Therapeutic Efficacy of Tiludronic Acid on Inner Ear Involvement in Advanced Otosclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tiludronic acid for inner ear involvement in advanced otosclerosis. The study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tiludronic Acid (tiludronic acid)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Otosclerosis | Phase 3 | Status: TERMINATED